松田 諭

Medicine & Life Sciences

1. Esophagectomy 100%
2. Esophageal Neoplasms 88%
3. Esophageal Squamous Cell Carcinoma 62%
4. Survival 30%
5. Stomach Neoplasms 29%
6. Lymph Nodes 24%
7. Fibrinogen 21%
8. Thoracic Duct 21%
9. Chemoradiotherapy 20%
10. Lymph Node Excision 20%
11. Neoplasm Metastasis 19%
12. Recurrence 19%
13. Postoperative Complications 16%
14. Albumins 16%
15. Gastrectomy 14%
16. Japan 14%
17. Drug Therapy 14%
18. Serum Albumin 12%
19. Neoadjuvant Therapy 11%
20. Stomach 10%
21. Dissection 10%
22. Neoplasms 9%
23. Pneumonia 8%
24. Thorax 8%
25. squamous cell carcinoma-related antigen 7%
26. Cohort Studies 7%
27. Medical Oncology 7%
28. Psoas Muscles 7%
29. Therapeutics 7%
30. Prospective Studies 7%
31. Esophagogastric Junction 6%
32. Serum 6%
33. Acute Liver Failure 6%
34. Community Hospital 5%
35. Validation Studies 5%
36. Cisplatin 5%
37. Multivariate Analysis 5%
38. Venous Thromboembolism 5%
39. Gene Expression Regulation 5%
40. C-Reactive Protein 5%
41. Interleukin-6 5%
42. Sputum 5%
43. Mitosis 5%
44. Adenocarcinoma 5%